388 results on '"Zuily, Stéphane"'
Search Results
52. Influence of Age and Renal Function on High-Sensitivity Cardiac Troponin T Diagnostic Accuracy for the Diagnosis of Acute Myocardial Infarction
53. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses
54. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials
55. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
56. Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies
57. Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: A pilot study
58. Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody–Positive Patients with Livedo
59. Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
60. Supplemental Material - Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses
61. The Challenge of Bleeding in Antiphospholipid Antibody-Positive Patients
62. Pulmonary Hypertension in Antiphospholipid Syndrome
63. Liste des collaborateurs
64. Atteinte artérielle du syndrome des antiphospholipides
65. Impact of heart failure management unit on heart failure-related readmission rate and mortality
66. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment
67. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
68. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials.
69. Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies.
70. Valvular Heart Disease in Antiphospholipid Syndrome
71. Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopenia
72. Chapitre 134 - Hémoglobinurie paroxystique nocturne
73. Chapitre 133 - Syndrome des antiphospholipides
74. Chapitre 109 - Diagnostic, place des explorations
75. A Giant Abdominal Aortic Aneurysm Revealing a Marfan Syndrome With a New FBN1 Mutation
76. How to limit radial artery spasm during percutaneous coronary interventions: The spasmolytic agents to avoid spasm during transradial percutaneous coronary interventions (SPASM3) study
77. Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
78. Corrigendum to “Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis” [AUTREV 18–11 (2019) 102395]
79. Pathogeny of cerebral venous thrombosis in SARS-Cov-2 infection
80. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
81. Attitude des médecins vasculaires vis-à-vis de la contraception lors d’un événement thrombotique veineux en contexte hormonal
82. Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
83. Liste des auteurs
84. Liste des Auteurs
85. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
86. Vascular manifestations and kyphoscoliosis due to a novel mutation of PLOD1 gene
87. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
88. E‐health education interventions on HbA1cin patients with type 1 diabetes on intensive insulin therapy: A systematic review and meta‐analysis of randomized controlled trials
89. sj-pdf-1-lup-10.1177_0961203320940776 - Supplemental material for Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
90. Extended persistence of antiphospholipid antibodies beyond the twelve‐week time interval: Association with baseline antiphospholipid antibodies titres
91. Anomalies congénitales de la veine cave inférieure : rappels embryologiques, principales formes et conséquences cliniques.
92. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSCSubcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
93. COVID-19 : Quelques pistes pour un nouvel environnement d’enseignement et d’apprentissage en contexte de mise à distance des enseignants et des étudiants en médecine
94. Extended persistence of antiphospholipid antibodies beyond the 12‐week time interval: Association with baseline antiphospholipid antibodies titres
95. Heart valve involvement in antiphospholipid syndrome: More than you think!
96. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: A systematic review and meta‐analysis: Comment
97. Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms
98. Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
99. E-health education interventions on HbA1c in patients with type 1 diabetes on intensive insulin therapy: A systematic review and meta-analysis of randomized controlled trials.
100. The Isotype of Antiphospholipid Antibodies and Their Associated Risk on Thrombosis and Pregnancy Morbidity; What Are the Odds?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.